Skip to main content
Caplight Logo









MBQ Pharma

MBQ Pharma

Private
San Juan, Puerto RicoHealthcare & Life Scienceshttps://mbqpharma.com/

Last Round

Seed Round

Aug 14, 2026

Total Funding Raised

$4.8M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MBQ Pharma is a biotechnology company that develops targeted therapeutic compounds for the treatment of cancer, autoimmune diseases, and chronic fibrotic syndromes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall molecule therapeuticsdrug discoveryanti-metastatic agentsoncologyclinical trialsmetastasis inhibitiontriple-negative breast cancerTNBCdrug pipelinebiotech startupcancer researchprecision medicinetherapeutic developmentpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MBQ Pharma Comparables

Compare MBQ Pharma with similar companies based on industry and business-model similarity.

MBQ Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Revere Pharmaceuticals
84%
AXIM Biotechnologies, Inc.
84%
Novita Pharmaceuticals
82%

MBQ Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 14, 2026
Seed RoundAug 14, 2026
Seed RoundAug 14, 2026
Seed RoundAug 14, 2026
Seed RoundAug 14, 2026
Pre Seed
Jan 1, 2025

Key People

Founding team and executive leadership

Jose F. Rodriguez-Orengo

Chief Executive Officer

Executive Team

Carlos Domínguez Rullán

Chief Financial Officer

Executive Team

MBQ Pharma Investors

Notable investors and investment history

MBQ Pharma investors
InvestorRounds
Congressionally Directed Medical Research ProgramsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 14, 2026

    Raised $991K in Seed funding.

  • Aug 14, 2026

    $500K round completed.

MBQ Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MBQ Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MBQ Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Juan, Puerto Rico
Employee Range4
Year Founded2018
Last FundingAug 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?